Zidovudine-induced experimental myopathy: Dual mechanism of mitochondrial damage

Journal of the Neurological Sciences

Volumn 166, Issue 2, 1999, Pages 131-140

  Masini, Alberto ^a   Scotti, Claudia ^b   Calligaro, Alberto ^b   Cazzalini, Ornella ^b   Stivala, Lucia Anna ^b   Bianchi, Livia ^b   Giovannini, Fabiola ^a   Ceccarelli, Daniela ^a   Muscatello, Umberto ^a   Tomasi, Aldo ^a   Vannini, Vanio ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Electron microscopy; Energy transduction; Membrane potential; Mitochondrial anomalies; Myopathy; Zidovudine

Indexed keywords

MITOCHONDRIAL DNA; ZIDOVUDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON MICROSCOPY; ENERGY; FEMALE; HISTOCHEMISTRY; MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MUSCLE MITOCHONDRION; MYOPATHY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; RESPIRATORY CHAIN; ULTRASTRUCTURE;

ANIMALS; ANTI-HIV AGENTS; DNA, MITOCHONDRIAL; FEMALE; MITOCHONDRIAL MYOPATHIES; MUSCLE FIBERS; OXIDATION-REDUCTION; PHOSPHORYLATION; RATS; RATS, WISTAR; ZIDOVUDINE;

EID: 0032776374     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00126-4     Document Type: Article

References (32)

1. Dalakas M.C., Illa I., Pezeshokpour M.D.J.P.L., Cohen B. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med. 322:1990;1098-1105.
2. Weissman J.D., Constantinis I., Hudgins P., Wallace D.C. 31P magnetic resonance spectroscopy suggested impaired mitochondrial function in AZT-treated HIV-infected patients. Neurology. 42:1992;519-623.
3. Dalakas M.C., Leon-Monzon M.E., Bernardini I., Gahl W.A., Jay C.A. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage. Ann. Neurol. 53:1994;482-487.
4. Benbrik E., Chariot P., Bonavaud S., Ammi-Said M., Frisdal E., Rey C., Gherardi R., Barlovatz-Meimon G. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and salcitabine (ddC) on cultured human muscle cells. J Neurol Sci. 149:1997;19-25.
5. Arnaudo E., Dalakas M., Shanske S., Moraes C.T., DiMauro S., Schon E.A. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet. 337:(8740):1991;508-510.
6. Lamperth L., Dalakas M.C., Dagani F., Anderson J., Ferrari R. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab Invest. 65:1991;742-751.
7. Lewis W., Dalakas M.C. Mitochondrial activity of antiviral drugs. Nature Med. 1:1995;417-422.
8. Mhiri C., Baudrimont M., Bonne G., Geny C., Degoul F., Marsac C., Roullet E., Gherardi R. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction. Ann Neurol. 29:1991;606-614.
9. Modica-Napolitano J.S. AZT causes tissue-specific inhibition of mitochondrial bioenergetic function. Biochem Biophys Res Commun. 194:1993;170-177.
10. Lewis W., Gonzalez B., Chomyn A., Papoian T. Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria. J Clin Invest. 89:1992;1354-1360.
11. Pearse A.G.E. Histochemistry, theoretical and applied. 1972;Churchill and Livingstone, Edinburgh.
12. Makinen M.W., Lee C.-P. Biochemical studies of skeletal muscles mitochondria. I. Microanalysis of cytochrome content, oxidative and phosphorylative activities of mammalian skeletal muscle mitochondria. Arch Biochem Biophys. 126:1968;75-82.
13. Kamo N., Muratsugu M., Hongoh R., Kobatake Y. Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. J Membr Biol. 49:1979;105-121.
14. Masini A., Ceccarelli-Stanzani D., Muscatello U. The effect of oligomycin on rat liver mitochondria respiring in state 4. FEBS Lett. 160:1983;137-140.
15. Kornberg A. Lactic dehydrogenase of muscle. Methods Enzymol. 1:1955;441-443.
16. Cahn R.D., Kaplan N.O., Levine L. Nature and development of lactic dehydrogenase. Science. 136:1962;962-969.
17. Wilson A.C., Chan R.D., Kaplan N.O. Functions of the two forms of lactic dehydrogenase in the breast muscle of birds. Nature. 197:1963;331-334.
18. Black J.T., Judge D., Demers L., Gordon S. Ragged-red fibers. A biochemical and morphological study. J Neurol Sci. 26:1975;479-488.
19. Moreno A.J.M., Madeira V.M.C. Mitochondrial bioenergetics as affected by DDT. Biochim Biophys Acta. 1060:1991;166-174.
20. Heiman M. Copyright 1997, http:/www.medkem.gu.se/cutter.
21. Azzi A., Santato M. Energy-dependent interaction of oligomycin and dicyclohexylcarbodiimide with the mitochondrial membrane. FEBS Lett. 7:1970;135-138.
22. Barile M., Valenti D., Passarella S., Quagliariello E. 3′-Azido-3′-deoxythymidine uptake into isolated rat liver mitochondria and impairment of ADP/ATP translocator. Biochem Pharmacol. 53:(7):1997;913-920.
23. Simpson M.V., Chin C.D., Keybaugh S.A., Lin T.S., Prusoff W.H. Studies on the inhibition of mitochondrial DNA replication of 3′-azido-3′-deoxythymidine and other dideoxy nucleoside analogs which inhibit HIV-1 replication. Biochem Pharmacol. 38:1989;1033-1066.
24. Starnes M.C., Cheng Y.C. Cellular metabolism of 2′,3′-dideoxycytidine, a compound active against human immunodeficiency virus in vitro. J Biol Chem. 262:1987;988-991.
25. Reyes M.G., Casanova J., Varricchio F., Sequeira W., Fresco K. Zidovudine myopathy. Neurology. 42:(6):1992;1252.
26. d'Amati G., Lewis W. Zidovudine causes early increases in mitochondrial ribonucleic acid abundance and induces ultrastructural changes in cultured mouse muscle cells. Lab Invest. 71:(6):1994;879-884.
27. Jackman M.R., Willis W.T. Characteristics of mitochondria isolated from type I and type IIb skeletal muscle. Am. J. Physiol. 270:(2 Pt 1):1996;C673-C678.
28. Kuznetsov A.V., Tiivel T., Sikk P., Kaambre T., Kay L., Daneshrad Z., Rossi A., Kadaja L., Peet N., Seppet E., Saks V.A. Striking differences between the kinetics of regulation of respiration by ADP in slow-twitch and fast-twitch muscles in vivo. Eur J Biochem. 241:(3):1996;909-915.
29. Muscatello U., Margreth A., Aloisi M. On the differential response of sarcoplasm and myoplasm to denervation in frog muscle. J Cell Biol. 27:(1):1965;1-24.
30. Takekura H., Kasuga N., Kitada K., Yoshioka T. Morphological changes in the triads and sarcoplasmic reticulum of rat slow and fast muscle fibres following denervation and immobilization. J Muscle Res. 17:1996;391-400.
31. ++ isoforms in denervated, regenerating and dystrophic chicken skeletal muscle. Dev Biol. 144:1991;199-211.
32. Nozais M., Lompre A.M., Janmot C.A.D.A. Sarco(endo)plasmic reticulum Ca2+ pump and metabolic enzyme expression in rabbit fast-type and slow-type denervated skeletal muscles. A time course study. Eur J Biochem. 238:(3):1996;807-812.